Pages that link to "Item:Q4666658"
From MaRDI portal
The following pages link to Modification of Sample Size in Group Sequential Clinical Trials (Q4666658):
Displayed 26 items.
- Basic concepts of group sequential and adaptive group sequential test procedures (Q1580842) (← links)
- Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
- Sequential monitoring of response-adaptive randomized clinical trials with sample size re-estimation (Q2301050) (← links)
- Optimal two-stage group-sequential designs (Q2475735) (← links)
- An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size (Q2927605) (← links)
- Internal pilots for observational studies (Q3056474) (← links)
- Impacts on type I error rate with inappropriate use of learn and confirm in confirmatory adaptive design trials (Q3076083) (← links)
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches (Q3078835) (← links)
- Self-Designing Two-Stage Trials to Minimize Expected Costs (Q3078967) (← links)
- Sequential Tests for Noninferiority and Superiority (Q3079082) (← links)
- Are Flexible Designs Sound? (Q3436501) (← links)
- Optimal Conditional Error Functions for the Control of Conditional Power (Q3445294) (← links)
- Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials (Q3445330) (← links)
- Exact Confidence Bounds Following Adaptive Group Sequential Tests (Q3637002) (← links)
- Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069) (← links)
- Interim Analysis and Sample Size Reassessment (Q4670476) (← links)
- Comparison of Operating Characteristics of Commonly Used Sample Size Re-Estimation Procedures in a Two-Stage Design (Q4921621) (← links)
- Adaptive designs for noninferiority trials (Q4921949) (← links)
- Partition testing in confirmatory adaptive designs with structured objectives (Q4921952) (← links)
- Finite-Sample Two-Group Composite Hypothesis Testing via Machine Learning (Q5057095) (← links)
- Seamless phase II/III/IIIb clinical trial designs with different endpoints for different phases (Q5078036) (← links)
- Distribution theory following blinded and unblinded sample size re-estimation under parametric models (Q5082954) (← links)
- Simulation of clinical trials: a review with emphasis on the design issues (Q5148592) (← links)
- Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations (Q5714618) (← links)
- Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints (Q6068468) (← links)
- Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events (Q6068480) (← links)